Viatris Inc. (VTRS)
USD 7.63
(1.19%)
USD 7.63
(1.19%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 15.42 Billion USD | -5.14% |
| 2022 | 16.26 Billion USD | -9.08% |
| 2021 | 17.88 Billion USD | 49.73% |
| 2020 | 11.94 Billion USD | 3.87% |
| 2019 | 11.5 Billion USD | 0.58% |
| 2018 | 11.43 Billion USD | -3.98% |
| 2017 | 11.9 Billion USD | 7.5% |
| 2016 | 11.07 Billion USD | 17.47% |
| 2015 | 9.42 Billion USD | 22.15% |
| 2014 | 7.71 Billion USD | 11.73% |
| 2013 | 6.9 Billion USD | 1.01% |
| 2012 | 6.84 Billion USD | 11.49% |
| 2011 | 6.13 Billion USD | 12.61% |
| 2010 | 5.44 Billion USD | 6.98% |
| 2009 | 5.09 Billion USD | -0.87% |
| 2008 | 5.13 Billion USD | 76.85% |
| 2007 | 2.9 Billion USD | 0.0% |
| 2006 | 1.25 Billion USD | 0.3% |
| 2005 | 1.25 Billion USD | 0.3% |
| 2004 | 1.25 Billion USD | -8.82% |
| 2003 | 1.37 Billion USD | 0.0% |
| 2002 | 1.1 Billion USD | 30.4% |
| 2001 | 846.69 Million USD | 7.16% |
| 2000 | 790.14 Million USD | 9.57% |
| 1999 | 721.1 Million USD | 36.42% |
| 1998 | 528.6 Million USD | 20.08% |
| 1997 | 440.2 Million USD | 12.04% |
| 1996 | 392.9 Million USD | -0.81% |
| 1995 | 396.1 Million USD | 57.31% |
| 1994 | 251.8 Million USD | 18.77% |
| 1993 | 212 Million USD | 60.73% |
| 1992 | 131.9 Million USD | 44.79% |
| 1991 | 91.1 Million USD | -4.51% |
| 1990 | 95.4 Million USD | 8.53% |
| 1989 | 87.9 Million USD | -8.44% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 3.66 Billion USD | -4.53% |
| 2024 Q2 | 3.79 Billion USD | 3.64% |
| 2023 Q2 | 3.91 Billion USD | 5.08% |
| 2023 Q3 | 3.94 Billion USD | 0.59% |
| 2023 Q4 | 3.83 Billion USD | -2.65% |
| 2023 Q1 | 3.72 Billion USD | -3.79% |
| 2023 FY | 15.38 Billion USD | -5.42% |
| 2022 Q4 | 3.87 Billion USD | -4.96% |
| 2022 FY | 16.26 Billion USD | -9.08% |
| 2022 Q3 | 4.07 Billion USD | -0.94% |
| 2022 Q2 | 4.11 Billion USD | -1.79% |
| 2022 Q1 | 4.19 Billion USD | -3.45% |
| 2021 Q4 | 4.34 Billion USD | -4.3% |
| 2021 Q2 | 4.57 Billion USD | 3.33% |
| 2021 Q3 | 4.53 Billion USD | -0.9% |
| 2021 FY | 17.88 Billion USD | 49.73% |
| 2021 Q1 | 4.43 Billion USD | 22.27% |
| 2020 Q4 | 3.62 Billion USD | 21.92% |
| 2020 Q1 | 2.61 Billion USD | -17.94% |
| 2020 Q2 | 2.73 Billion USD | 4.28% |
| 2020 Q3 | 2.97 Billion USD | 8.82% |
| 2020 FY | 11.94 Billion USD | 3.87% |
| 2019 FY | 11.5 Billion USD | 0.58% |
| 2019 Q3 | 2.96 Billion USD | 3.86% |
| 2019 Q4 | 3.19 Billion USD | 7.77% |
| 2019 Q1 | 2.49 Billion USD | -18.94% |
| 2019 Q2 | 2.85 Billion USD | 14.27% |
| 2018 Q4 | 3.07 Billion USD | 7.56% |
| 2018 Q1 | 2.68 Billion USD | -17.12% |
| 2018 FY | 11.43 Billion USD | -3.98% |
| 2018 Q2 | 2.8 Billion USD | 4.61% |
| 2018 Q3 | 2.86 Billion USD | 1.93% |
| 2017 Q2 | 2.96 Billion USD | 8.92% |
| 2017 Q1 | 2.71 Billion USD | -16.78% |
| 2017 FY | 11.9 Billion USD | 7.5% |
| 2017 Q3 | 2.98 Billion USD | 0.84% |
| 2017 Q4 | 3.23 Billion USD | 8.43% |
| 2016 Q2 | 2.56 Billion USD | 16.86% |
| 2016 Q3 | 3.05 Billion USD | 19.39% |
| 2016 Q4 | 3.26 Billion USD | 6.89% |
| 2016 FY | 11.07 Billion USD | 17.47% |
| 2016 Q1 | 2.19 Billion USD | -12.02% |
| 2015 Q3 | 2.69 Billion USD | 13.64% |
| 2015 Q1 | 1.87 Billion USD | -10.13% |
| 2015 FY | 9.42 Billion USD | 22.15% |
| 2015 Q4 | 2.49 Billion USD | -7.59% |
| 2015 Q2 | 2.37 Billion USD | 26.71% |
| 2014 Q3 | 2.08 Billion USD | 13.43% |
| 2014 Q2 | 1.83 Billion USD | 7.09% |
| 2014 Q1 | 1.71 Billion USD | -5.14% |
| 2014 Q4 | 2.08 Billion USD | -0.06% |
| 2014 FY | 7.71 Billion USD | 11.73% |
| 2013 Q3 | 1.76 Billion USD | 0.0% |
| 2013 Q1 | 1.63 Billion USD | -5.3% |
| 2013 Q4 | 1.8 Billion USD | 2.33% |
| 2013 FY | 6.9 Billion USD | 1.66% |
| 2013 Q2 | 1.7 Billion USD | 4.3% |
| 2012 FY | 6.79 Billion USD | 10.87% |
| 2012 Q4 | 1.72 Billion USD | -4.8% |
| 2012 Q3 | 1.8 Billion USD | 6.99% |
| 2012 Q2 | 1.69 Billion USD | 6.23% |
| 2012 Q1 | 1.59 Billion USD | 4.0% |
| 2011 Q1 | 1.44 Billion USD | 1.01% |
| 2011 FY | 6.12 Billion USD | 12.46% |
| 2011 Q2 | 1.57 Billion USD | 8.62% |
| 2011 Q4 | 1.53 Billion USD | -2.83% |
| 2011 Q3 | 1.57 Billion USD | 0.12% |
| 2010 Q4 | 1.43 Billion USD | 5.86% |
| 2010 Q1 | 1.29 Billion USD | -4.4% |
| 2010 Q2 | 1.36 Billion USD | 5.89% |
| 2010 Q3 | 1.35 Billion USD | -0.98% |
| 2010 FY | 5.45 Billion USD | 7.02% |
| 2009 Q3 | 1.26 Billion USD | -0.23% |
| 2009 Q4 | 1.35 Billion USD | 6.94% |
| 2009 Q1 | 1.2 Billion USD | 0.56% |
| 2009 FY | 5.09 Billion USD | -0.87% |
| 2009 Q2 | 1.26 Billion USD | 4.72% |
| 2008 Q4 | 1.2 Billion USD | -27.38% |
| 2008 Q3 | 1.65 Billion USD | 37.71% |
| 2008 Q1 | 1.07 Billion USD | 0.0% |
| 2008 Q2 | 1.2 Billion USD | 11.97% |
| 2008 FY | 5.13 Billion USD | 218.74% |
| 2007 Q3 | 477.09 Million USD | -12.67% |
| 2007 Q4 | - USD | -100.0% |
| 2007 FY | 1.61 Billion USD | 28.21% |
| 2007 Q1 | 487.26 Million USD | 21.28% |
| 2007 Q2 | 546.32 Million USD | 12.12% |
| 2006 Q2 | 356.14 Million USD | 9.73% |
| 2006 FY | 1.25 Billion USD | 0.3% |
| 2006 Q1 | 324.54 Million USD | 4.27% |
| 2006 Q3 | 366.65 Million USD | 2.95% |
| 2006 Q4 | 401.76 Million USD | 9.57% |
| 2005 Q2 | 323.37 Million USD | 2.19% |
| 2005 Q1 | 316.43 Million USD | 8.75% |
| 2005 FY | 1.25 Billion USD | -8.82% |
| 2005 Q4 | 311.24 Million USD | 4.45% |
| 2005 Q3 | 297.99 Million USD | -7.85% |
| 2004 Q2 | 339.01 Million USD | 1.69% |
| 2004 Q3 | 306.95 Million USD | -9.46% |
| 2004 Q4 | 290.97 Million USD | -5.21% |
| 2004 FY | 1.37 Billion USD | 8.31% |
| 2004 Q1 | 333.36 Million USD | -4.7% |
| 2003 Q2 | 331.4 Million USD | -6.3% |
| 2003 Q1 | 353.68 Million USD | 10.36% |
| 2003 Q4 | 349.78 Million USD | -2.85% |
| 2003 FY | 1.26 Billion USD | 14.96% |
| 2003 Q3 | 360.06 Million USD | 8.65% |
| 2002 FY | 1.1 Billion USD | 30.4% |
| 2002 Q4 | 320.49 Million USD | 0.3% |
| 2002 Q3 | 319.53 Million USD | 16.0% |
| 2002 Q2 | 275.47 Million USD | -2.52% |
| 2002 Q1 | 282.59 Million USD | -4.91% |
| 2001 Q4 | 297.19 Million USD | 3.79% |
| 2001 Q2 | 237.93 Million USD | -4.31% |
| 2001 Q1 | 248.64 Million USD | 11.38% |
| 2001 FY | 846.69 Million USD | 7.16% |
| 2001 Q3 | 286.32 Million USD | 20.34% |
| 2000 Q1 | 214.64 Million USD | 5.27% |
| 2000 Q4 | 223.23 Million USD | 7.56% |
| 2000 Q3 | 207.55 Million USD | 24.09% |
| 2000 Q2 | 167.25 Million USD | -22.08% |
| 2000 FY | 790.14 Million USD | 9.57% |
| 1999 FY | 721.1 Million USD | 36.42% |
| 1999 Q1 | 190.6 Million USD | 2.36% |
| 1999 Q2 | 177.1 Million USD | -7.08% |
| 1999 Q3 | 194.5 Million USD | 9.82% |
| 1999 Q4 | 203.9 Million USD | 4.83% |
| 1998 Q2 | 166.7 Million USD | 22.66% |
| 1998 FY | 528.6 Million USD | 20.08% |
| 1998 Q3 | 177.6 Million USD | 6.54% |
| 1998 Q4 | 186.2 Million USD | 4.84% |
| 1998 Q1 | 135.9 Million USD | 4.94% |
| 1997 Q1 | 118.7 Million USD | 4.12% |
| 1997 FY | 440.2 Million USD | 12.04% |
| 1997 Q4 | 129.5 Million USD | -15.91% |
| 1997 Q3 | 154 Million USD | 41.03% |
| 1997 Q2 | 109.2 Million USD | -8.0% |
| 1996 FY | 392.9 Million USD | -0.81% |
| 1996 Q2 | 98.5 Million USD | 4.01% |
| 1996 Q4 | 114 Million USD | 4.59% |
| 1996 Q3 | 109 Million USD | 10.66% |
| 1996 Q1 | 94.7 Million USD | 3.72% |
| 1995 Q1 | 110.7 Million USD | 6.14% |
| 1995 FY | 396.1 Million USD | 57.31% |
| 1995 Q2 | 109.2 Million USD | -1.36% |
| 1995 Q4 | 91.3 Million USD | -6.55% |
| 1995 Q3 | 97.7 Million USD | -10.53% |
| 1994 Q4 | 104.3 Million USD | 8.65% |
| 1994 Q1 | 69.1 Million USD | 4.07% |
| 1994 Q3 | 96 Million USD | 12.81% |
| 1994 Q2 | 85.1 Million USD | 23.15% |
| 1994 FY | 251.8 Million USD | 18.77% |
| 1993 Q3 | 57.8 Million USD | -1.2% |
| 1993 Q4 | 66.4 Million USD | 14.88% |
| 1993 FY | 212 Million USD | 60.73% |
| 1993 Q1 | 61 Million USD | -0.16% |
| 1993 Q2 | 58.5 Million USD | -4.1% |
| 1992 Q3 | 51 Million USD | 31.44% |
| 1992 Q1 | 38.8 Million USD | 11.17% |
| 1992 FY | 131.9 Million USD | 44.79% |
| 1992 Q2 | 38.8 Million USD | 0.0% |
| 1992 Q4 | 61.1 Million USD | 19.8% |
| 1991 Q3 | 26.2 Million USD | 11.97% |
| 1991 Q1 | 24 Million USD | 4.8% |
| 1991 Q4 | 34.9 Million USD | 33.21% |
| 1991 FY | 91.1 Million USD | -4.51% |
| 1991 Q2 | 23.4 Million USD | -2.5% |
| 1990 Q2 | 23.3 Million USD | -14.02% |
| 1990 FY | 95.4 Million USD | 8.53% |
| 1990 Q4 | 22.9 Million USD | 9.57% |
| 1990 Q1 | 27.1 Million USD | 12.45% |
| 1990 Q3 | 20.9 Million USD | -10.3% |
| 1989 Q2 | 21.1 Million USD | -1.86% |
| 1989 FY | 87.9 Million USD | -8.44% |
| 1989 Q1 | 21.5 Million USD | -3.15% |
| 1989 Q4 | 24.1 Million USD | 3.88% |
| 1989 Q3 | 23.2 Million USD | 9.95% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 566.76 Million USD | -2621.912% |
| Embecta Corp. | 1.12 Billion USD | -1276.419% |
| ANI Pharmaceuticals, Inc. | 486.81 Million USD | -3068.939% |
| Dynavax Technologies Corporation | 232.28 Million USD | -6541.396% |
| Esperion Therapeutics, Inc. | 116.33 Million USD | -13160.87% |
| Pacira BioSciences, Inc. | 674.97 Million USD | -2185.541% |
| PainReform Ltd. | - USD | -Infinity% |
| Aquestive Therapeutics, Inc. | 50.58 Million USD | -30398.191% |
| Sunshine Biopharma, Inc. | 24.09 Million USD | -63931.197% |
| SCYNEXIS, Inc. | 140.14 Million USD | -10908.128% |
| China SXT Pharmaceuticals, Inc. | 1.92 Million USD | -799844.205% |
| Cosmos Health Inc. | 53.37 Million USD | -28801.842% |
| Journey Medical Corporation | 79.18 Million USD | -19383.083% |
| Sunshine Biopharma, Inc. | 24.09 Million USD | -63931.197% |
| Safety Shot Inc | 202.67 Thousand USD | -7611732.042% |
| Alpha Teknova, Inc. | 36.68 Million USD | -41953.484% |
| Intra-Cellular Therapies, Inc. | 464.37 Million USD | -3222.114% |
| Bright Green Corporation | 401.49 Thousand USD | -3842302.445% |
| Procaps Group, S.A. | 409.92 Million USD | -3663.393% |
| Theratechnologies Inc. | 81.76 Million USD | -18767.595% |
| Harrow Health, Inc. | 130.19 Million USD | -11749.255% |
| Sonoma Pharmaceuticals, Inc. | 12.73 Million USD | -121037.809% |
| Biofrontera Inc. | 34.07 Million USD | -45178.683% |
| DURECT Corporation | 8.54 Million USD | -180373.795% |
| Supernus Pharmaceuticals, Inc. | 607.52 Million USD | -2439.32% |
| Cronos Group Inc. | 88.84 Million USD | -17264.638% |
| OptiNose, Inc. | 70.98 Million USD | -21632.007% |
| Ironwood Pharmaceuticals, Inc. | 442.73 Million USD | -3384.455% |
| Kala Pharmaceuticals, Inc. | - USD | -Infinity% |
| RedHill Biopharma Ltd. | 6.51 Million USD | -236756.905% |
| Organogenesis Holdings Inc. | 433.14 Million USD | -3461.643% |
| Guardion Health Sciences, Inc. | 12.24 Million USD | -125848.786% |
| Cumberland Pharmaceuticals Inc. | 39.55 Million USD | -38903.596% |
| Radius Health, Inc. | 2.88 Billion USD | -435.243% |
| Universe Pharmaceuticals INC | 32.3 Million USD | -47648.388% |
| ProPhase Labs, Inc. | 44.38 Million USD | -34657.796% |
| Phibro Animal Health Corporation | 1.01 Billion USD | -1415.891% |
| Procaps Group S.A. | 409.92 Million USD | -3663.393% |
| Alvotech | 91.43 Million USD | -16772.17% |
| TherapeuticsMD, Inc. | 1.3 Million USD | -1184761.751% |
| Rockwell Medical, Inc. | 83.61 Million USD | -18350.581% |
| Aytu BioPharma, Inc. | 81 Million USD | -18945.085% |
| SIGA Technologies, Inc. | 139.91 Million USD | -10925.734% |
| Tilray Brands, Inc. | 788.94 Million USD | -1855.391% |
| Lifecore Biomedical, Inc. | 128.26 Million USD | -11927.74% |
| Shineco, Inc. | 9.8 Million USD | -157287.54% |
| PetIQ, Inc. | 1.1 Billion USD | -1299.947% |
| Regencell Bioscience Holdings Limited | - USD | -Infinity% |
| Incannex Healthcare Limited | 12 Thousand USD | -128557400.0% |
| Neurocrine Biosciences, Inc. | 1.88 Billion USD | -717.492% |
| Alimera Sciences, Inc. | 80.75 Million USD | -19003.574% |
| Silver Spike Investment Corp. | 11.72 Million USD | -131504.888% |
| Assertio Holdings, Inc. | 152.06 Million USD | -10044.671% |
| Shuttle Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Petros Pharmaceuticals, Inc. | 5.82 Million USD | -264858.295% |
| Clever Leaves Holdings Inc. | 17.41 Million USD | -88473.807% |
| Cyclo Therapeutics, Inc. | 1.07 Million USD | -1433087.323% |
| Avadel Pharmaceuticals plc | 27.96 Million USD | -55068.973% |
| Hempacco Co., Inc. | 4.04 Million USD | -381221.903% |
| Talphera, Inc. | 651 Thousand USD | -2369623.502% |
| Alvotech | 91.43 Million USD | -16772.17% |
| Eagle Pharmaceuticals, Inc. | 316.61 Million USD | -4772.525% |
| Lantheus Holdings, Inc. | 1.29 Billion USD | -1089.953% |
| Currenc Group, Inc. | 53.25 Million USD | -28867.788% |
| Kamada Ltd. | 144.75 Million USD | -10556.97% |
| Indivior PLC | 1.09 Billion USD | -1311.427% |
| Evoke Pharma, Inc. | 5.18 Million USD | -297680.386% |
| Flora Growth Corp. | 76.07 Million USD | -20179.607% |
| Cyclo Therapeutics, Inc. | 1.07 Million USD | -1433087.323% |
| Evolus, Inc. | 202.08 Million USD | -7533.867% |
| HUTCHMED (China) Limited | 837.99 Million USD | -1740.921% |
| Amphastar Pharmaceuticals, Inc. | 644.39 Million USD | -2294.013% |
| Akanda Corp. | 2.16 Million USD | -714091.14% |